ACADIA Pharmaceuticals Inc. (ACAD) NASDAQ

20.94

+0.05(+0.24%)

Updated at October 20 04:00PM

Currency In USD

Valuation

Market Cap3.04B
Enterprise Value2.77B
P/E Ratio16.07
PEG Ratio-5.54
Price/Sales Ratio3.52
Price/Book Ratio4.34
Enterprise/Revenue3.32
Enterprise/EBITDA31.79

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.22
Operating Margin0.23

Management Effectiveness

Return On Assets0.18
Return On Equity0.31

Income Statement

Revenue957.8M
Revenue/Share6.07
Gross Profit875.96M
EBITDA100.16M
Net Income226.45M
Diluted EPS1.36

Balance Sheet

Total Cash762M
Total Cash/Share4.54
Total Debt44.6M
Total Debt/Equity0.05
Current Ratio2.91
Book Value Per Share4.9

Price History

52-Week Change44.09
52-Week High26.65
52-Week Low13.4
Moving Average 50 Days23.57
Moving Average 200 Days20.24

Statistics

Average Volume2.08M
Shares Outstanding168.71M
% Held by Institutions101.21

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A